Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Experimental Dermatology, 2022Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris
Koschitzky M., Navrazhina K., Garshick M. et al.
Olink Target 96
Biomedicines, 2022Cerebrospinal Fluid in Classical Trigeminal Neuralgia: An Exploratory Study on Candidate Biomarkers
Svedung Wettervik T., Folkvaljon D., Gordh T. et al.
The American Journal of Pathology, 2022Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome
Price D., Benedetti E., Hoffman K. et al.
Translational Neurodegeneration, 2022Advances in the development of new biomarkers for Alzheimer’s disease
Klyucherev T., Olszewski P., Shalimova A. et al.
European Stroke Journal, 2022A novel biomarker panel index improves risk stratification after ischemic stroke
Bicvic A., Scherrer N., Schweizer J. et al.
Cell Reports, 2022Systems analysis shows a role of cytophilic antibodies in shaping innate tolerance to malaria
Lautenbach M., Yman V., Silva C. et al.
International Journal of Rheumatic Diseases, 2022Sex differences in circulating proteins of patients with rheumatoid arthritis: A cohort study
Ferreira M., Fonseca T., Costa R. et al.
Nature Communications, 2022Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia
Huuhtanen J., Bhattacharya D., Lönnberg T. et al.
Circulation, 2022Genetic Landscape of the ACE2 Coronavirus Receptor
Yang Z., Macdonald-Dunlop E., Chen J. et al.
Vasa, 2022Novel cardiovascular biomarkers associated with peripheral arterial disease in men screened for abdominal aortic aneurysm
Dakhel A., Memon A., Zarrouk M. et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022Proteomics approaches to characterize the immune responses in cancer
Urbiola-Salvador V., Miroszewska D., Jabłońska A. et al.
Nature Communications, 2022Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer
Minas T., Candia J., Dorsey T. et al.
International Journal of Molecular Sciences, 2022Machine-Learning Analysis of Serum Proteomics in Neuropathic Pain after Nerve Injury in Breast Cancer Surgery Points at Chemokine Signaling via SIRT2 Regulation
Lötsch J., Mustonen L., Harno H. et al.
Biomedicines, 2022Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis
Panezai J., Ghaffar A., Altamash M. et al.
Journal of Translational Medicine, 2022Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab
Sims J., Poorbaugh J., Chang C. et al.
Circulation, 2022Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization
Henry A., Gordillo-Marañón M., Finan C. et al.
ESC Heart Failure, 2022The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
Henkens M., van Ommen A., Remmelzwaal S. et al.
Scientific Reports, 2022Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions
Kopecky J., Pérez J., Eriksson H. et al.
The Journal of Clinical Endocrinology & Metabolism, 2022Proteomic Profiles of Body Mass Index and Waist-to-Hip Ratio and Their Role in Incidence of Diabetes
Bao X., Xu B., Yin S. et al.
Journal for ImmunoTherapy of Cancer, 2022Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study
Naing A., Powderly J., Nemunaitis J. et al.
3026 publications
Items per page
1321-1340 of 3026 publications